KATHERINE WINDRIM: Open Payments
NPI 1508234162 · CLARKSTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,891 in 203 payments from 17 companies in 2025. Trend: 2023 $2,614 · 2024 $2,949 · 2025 $3,891
Food & beverage: $3,792Education: $100
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 34 | $631 |
| Vanda Pharmaceuticals Inc. | 22 | $608 |
| Axsome Therapeutics, Inc. | 18 | $435 |
| Teva Pharmaceuticals USA, Inc. | 13 | $357 |
| Alkermes, Inc. | 14 | $340 |
| Otsuka America Pharmaceutical, Inc. | 10 | $247 |
| Janssen Pharmaceuticals, Inc | 9 | $232 |
| Lundbeck LLC | 10 | $191 |
| Corium, LLC | 15 | $185 |
| ABBVIE INC. | 27 | $168 |
Products named: CAPLYTA, FANAPT, Auvelity, REXULTI, ARISTADA, Azstarys, LOREEV XR, VRAYLAR.
Industry payments across MI — which companies pay providers there.
